The Portuguese Association for the Development of Communications (APDC) has rescheduled the 34th Digital Business Congress for July 1 and 2, following the early elections on May 18. The theme for this year’s event will be “Science & Business: Working Together.”
Maria Manuel Mota, CEO of the Gulbenkian Institute for Molecular Medicine (GIMM), expressed initial surprise at the event’s theme, wondering if there had been a mistake. The GIMM was formed from the merger of the Institute of Molecular Medicine (IMM) and the Gulbenkian Institute of Science (IGC).
Reflecting on APDC’s evolution, Mota noted that the association has shifted its focus toward digital business. She remarked on the relevance of this theme, acknowledging the ongoing digital transformation efforts within the GIMM Foundation and expressing interest in networking opportunities.
The congress’s emphasis on science and business collaboration sparked a dialogue about the interplay between discovery and commerce. Mota highlighted the importance of curiosity-driven scientific research, which must be protected even while its findings can eventually benefit society, the planet, and industry.
The potential for partnerships between scientific and business communities was a key consideration in accepting the congress’s invitation, which Mota saw as mutually beneficial. She expressed enthusiasm for the collaboration possibilities discussed in initial conversations with APDC.
Advocating for dialogue between science and business, Mota emphasized the need for effective communication, reflecting on GIMM’s legacy from both IMM, established 20 years ago, and IGC, founded in 1961. This foundation aims to translate scientific discoveries into practical applications for societal impact.
Despite potential challenges due to differing “languages” in science and business, Mota emphasized the need for mutual understanding without compromising individual approaches. She noted that successful communication could lead to mutual gains.
Discussing current research at GIMM, Mota mentioned ongoing discoveries and the institution’s prolific publishing record in significant scientific outlets. Recent contributions span various fields, including malaria, inflammation, and colorectal cancer research.
